Intravenous administration of SDF-1α/CXCL12-overexpressing MSCs one day after MI induction in a rat model has shown increased cardiac myocyte survival and vascular density within the infarct zone as compared to transplantation of normal MSCs [42]. This evidence concerns the gene CXCL12 and myocardial infarction.